 |
 |

Clinical Trial Registries
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: The status of and experiences with clinical trial registration were reviewed by Dr Zarin and colleagues.1 An issue that was not raised in this article was the unforeseen extra work generated for researchers as a result of the success of ClinicalTrials.gov in reaching the general public.
In the 2 years after registering a new investigation with ClinicalTrials.gov, I received hundreds of e-mails from patients and other nonclinicians. Most were interested in enrollment, even though the study had reached its target and was now closed. Some apparently viewed the e-mail link as access to obtain medical advice. A colleague contacted me for preliminary results before the trial was completed. I even received e-mails from persons trying sell me products for my office—ClinicalTrials.gov as a gateway to direct marketing!
It is likely that most researchers would feel obliged to answer such e-mail (except perhaps the spam). It is important . . . [Full Text of this Article]
Jais Oliver Berg, MD
joberg@dadlnet.dk Department of Plastic Surgery Odense University Hospital Odense, Denmark
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED LETTERS
Clinical Trial Registries
Jeffrey L. Saver
JAMA. 2007;298(13):1514.
EXTRACT
| FULL TEXT
Clinical Trial Registries—Reply
Deborah A. Zarin, Nicholas C. Ide, Tony Tse, William R. Harlan, and Donald A. B. Lindberg
JAMA. 2007;298(13):1515.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Issues in the Registration of Clinical Trials
Deborah A. Zarin, Nicholas C. Ide, Tony Tse, William R. Harlan, Joyce C. West, and Donald A. B. Lindberg
JAMA. 2007;297(19):2112-2120.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials
Mathieu et al.
JAMA 2009;302:977-984.
ABSTRACT
| FULL TEXT
|